Literature DB >> 6388325

Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.

J Cleland, P Semple, P Hodsman, S Ball, I Ford, H Dargie.   

Abstract

The angiotensin converting enzyme inhibitor captopril improves the altered hemodynamics in many patients with chronic heart failure, but the first dose may precipitate hypotension. Ten patients with chronic heart failure were studied, nine with high plasma concentrations of renin and one with a low concentration. Frequent measurements of plasma concentrations of angiotensin II, renin, and catecholamines were made over 60 minutes after a small dose (6.25 mg) of captopril and related to concurrently measured hemodynamic variables. Captopril caused a decrease in systemic and pulmonary artery pressure and an increase in cardiac index, and these changes coincided with reductions in the plasma concentrations of angiotensin II and increases in plasma concentrations of renin. The hemodynamic changes were accompanied by reductions in the plasma concentrations of norepinephrine but transient increases in plasma concentrations of epinephrine in patients in whom vasomotor syncope developed. The patient with a low plasma renin concentration showed little hemodynamic response to the drug. It is concluded that vasomotor syncope occurs quite frequently in patients with severe chronic heart failure after captopril in a small dose and is associated with a selective increase in epinephrine secretion from the adrenal medulla.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388325     DOI: 10.1016/0002-9343(84)90530-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

Review 1.  Vascular tone in heart failure: the neuroendocrine-therapeutic interface.

Authors:  J G Cleland; C M Oakley
Journal:  Br Heart J       Date:  1991-10

Review 2.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  Angiotensin converting enzyme inhibitors in the elderly.

Authors:  J P Milnes; A J Shaw
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-07

Review 4.  Angiotensin converting enzyme inhibitors in the elderly.

Authors:  J L Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

Review 5.  ACE inhibitors for heart failure: a question of dose.

Authors:  J G Cleland; P A Poole-Wilson
Journal:  Br Heart J       Date:  1994-09

6.  Antihypertensive effect of single doses of enalapril in hypertensive patients treated with bendrofluazide.

Authors:  J Webster; D Newnham; O J Robb; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

Review 7.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

8.  Early treatment with captopril after acute myocardial infarction.

Authors:  S G Ray; M Pye; K G Oldroyd; J Christie; D T Connelly; D B Northridge; I Ford; J J Morton; H J Dargie; S M Cobbe
Journal:  Br Heart J       Date:  1993-03

Review 9.  The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.

Authors:  R I Cargill; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

10.  Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.

Authors:  P F Semple; A M Cumming; P A Meredith; J J Morton
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.